| Cash flows from operating activities: | |
| Net loss | -24.45M |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | 128K |
| Accretion of discount on convertible notes | 4.13M |
| Change in valuation of warrant liability | |
| Warrant liability transferred to APIC upon exercise of warrant | |
| Amortization of deferred compensation related to restricted stock (including restricted stock awards that contain performance conditions) | |
| Amortization of deferred financing costs | 213K |
| Unrecognized tax benefit liability | |
| Deferred income taxes | |
| Stock compensation expense | 960K |
| Changes in: | |
| Accounts receivable, net | 517K |
| Inventories, net | 1.94M |
| Recoverable income taxes | |
| Prepaid expenses and other current assets | -1.13M |
| Accounts payable | -926K |
| Accrued interest on convertible notes | |
| Other current liabilities | -65K |
| Deferred revenues | -281K |
| Net cash used in operating activities | -27.08M |
| Cash flows from investing activities: | |
| Purchases of held-to-maturity securities (investments-short-term) | -686K |
| Capital expenditures | |
| Changes in other long-term assets | |
| Net cash used in investing activities | 13.31M |
| Cash flows from financing activities: | |
| Proceeds from issuance of common stock | 139K |
| Proceeds from issuance of convertible notes, net of expenses | |
| Changes in other long-term liabilities | |
| Net cash provided by financing activities | 139K |
| Net increase (decrease) in cash and cash equivalents | -14.19M |
| Cash and cash equivalents at beginning of period | 50.33M |
| Cash and cash equivalents at end of period | 36.14M |
| Other information: | |
| Income tax paid | 0 |
| Interest paid | 2.91M |